Skip to main content
Genmab logo

Genmab — Investor Relations & Filings

Ticker · GMAB ISIN · DK0010272202 LEI · 529900MTJPDPE4MHJ122 CO Manufacturing
Filings indexed 2,823 across all filing types
Latest filing 2020-01-20 Regulatory Filings
Country DK Denmark
Listing CO GMAB

Genmab is an international biotechnology company that specializes in the creation, development, and commercialization of differentiated antibody therapeutics. The company focuses on transforming the treatment of cancer and other serious diseases. By utilizing proprietary antibody technology platforms and scientific expertise, Genmab develops a pipeline of innovative medicines. Its activities span from discovery and research through clinical development to deliver novel therapies to patients.

Recent filings

Filing Released Lang Actions
Genmab Announces European Marketing Authorization for DARZALEX® (Daratumumab) in Combination with Bortezomib, Thalidomide and Dexamethasone in Frontline Multiple Myeloma
Regulatory Filings Classification · 95% confidence The document is titled "Company Announcement" and details the European Commission's marketing authorization for DARZALEX® (daratumumab) for a specific medical indication. It includes key highlights, context about the clinical study (CASSIOPEIA), and company background. This format—a brief, timely announcement of a significant corporate/regulatory event (drug approval) that is not a full financial report (like 10-K or IR) or a transcript—is characteristic of a general regulatory announcement or press release. Since it is a specific, material announcement that doesn't fit the other specialized categories (like DIV, DIRS, or ER), the most appropriate classification is the general regulatory filing/announcement category, RNS, as it serves as a broad disclosure mechanism.
2020-01-20 English
6-K
Foreign Filer Report
2020-01-02 English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
Director's Dealing Classification · 100% confidence The document is a formal notification of share transactions by company directors and executives (insider trading), specifically detailing the vesting of restricted stock units for multiple managerial employees. This aligns perfectly with the definition of 'Director's Dealing' (DIRS), which covers reports of personal share transactions by company directors and executives.
2020-01-02 English
Director's Dealing 2020
Director's Dealing Classification · 100% confidence The document is titled "Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons" and explicitly states it discloses data in accordance with Article 19 of Regulation No. 596/2014 (Market Abuse Regulation), which mandates reporting of insider transactions. This directly corresponds to the definition of Director's Dealing (insider trades by executives). Although it is a company announcement, the core subject matter is the transaction report itself, not just the announcement of a report's publication. Therefore, the most specific classification is DIRS.
2020-01-02 English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
Director's Dealing Classification · 98% confidence The document explicitly states it discloses 'data of the transactions made in Genmab A/S... made by managerial employees and their closely associated persons' in accordance with Article 19 of Regulation No. 596/2014 (Market Abuse Regulation). This regulation mandates the disclosure of insider transactions. The filing category 'Director's Dealing' (DIRS) specifically covers reports of personal share transactions by company directors and executives (insider trades). Although the document is short and includes an attachment link, the core content is the mandatory disclosure of insider transactions, making DIRS the most precise classification over a general RPA or RNS.
2020-01-02 English
6-K
Foreign Filer Report
2020-01-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.